國立虎尾科技大學 |

Hepatocellular Carcinoma = Diagnosis and Treatment /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Hepatocellular Carcinoma/ edited by Brian I. Carr.
Reminder of title:	Diagnosis and Treatment /
other author:	Carr, Brian I.
Description:	XXI, 596 p. 129 illus., 80 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Oncology . -
Online resource:	https://doi.org/10.1007/978-3-319-34214-6
ISBN:	9783319342146

Hepatocellular Carcinoma = Diagnosis and Treatment /
Hepatocellular CarcinomaDiagnosis and Treatment /[electronic resource] :edited by Brian I. Carr. - 3rd ed. 2016. - XXI, 596 p. 129 illus., 80 illus. in color.online resource. - Current Clinical Oncology,2364-1134 . - Current Clinical Oncology,.

Part A. Causes, Biological and Molecular bases of HCC -- Chapter 1. Epidemiology of Hepatocellular Carcinoma -- Chapter 2. Environmental Carcinogens and Risk for Human Liver Cancer -- Chapter 3. Molecular Mechanisms of Hepatocellular Carcinoma -- Chapter 4. Chemically-Induced Hepatocarcinogenesis -- Chapter 5. Molecular Profiling of Human Hepatocellular Carcinoma -- Chapter 6. Genomic signatures of risk factors and molecular identification of HCC subtypes -- Chapter 7. MicroRNAs and hepatocellular carcinoma -- Chapter 8. Non-tumor prognostic factors in hepatocellular carcinoma -- Chapter 9. Gut microbiota and HCC -- Chapter 10. Hepatocellular Carcinoma as a Paradigm for a Systemic Evolutionary Approach to Cancer -- Chapter 11. HCC and its Microenvironment -- Chapter 12. Circulating tumor cells (Liquid Tumor Biopsy) in hepatocellular carcinoma: biology, methodologies, and clinical implications -- Chapter 13. Role of the immune system in hepatocellular carcinoma: Implications for existing and novel therapies -- Chapter 14. Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma -- Chapter 15. Systemic inflammation: a new prognostic domain and source of therapeutic targets in hepatocellular carcinoma -- Chapter 16. Hepatocellular Carcinoma Associated with Hepatitis B virus -- Chapter 17. Hepatitis C and Hepatocellular Carcinoma -- Chapter 18. Obesity, NASH and HCC -- Chapter 19. Metabolic Disease and Hepatocellular Carcinoma -- Part B. Diagnosis -- Chapter 20. Pathologic Aspects of Hepatocellular Tumors -- Chapter 21. Protein biomarkers in the management of hepatocellular carcinoma: Novel combinatory approaches -- Chapter 22. Surveillance for hepatocellular carcinoma -- Chapter 23. Use of Imaging Techniques to Screen for Hepatocellular Carcinoma -- Chapter 24. Ultrasound of Hepatocellular Carcinoma: The Important Contribution of Contrast Enhancement -- Chapter 25. MRI for Detection and Evaluation of Hepatocellular Carcinoma -- Chapter 26. Computed Tomography of HCC -- Chapter 27. Clinical features and clinician's diagnostic approach to hepatocellular carcinoma -- Chapter 28. Current HCC Staging systems: their uses and limitations -- Part C. Therapies -- Chapter 29. Percutaneous Ethanol Injection -- Chapter 30. Thermal Ablative Treatments For Hepatocellular Carcinoma -- Chapter 31. Resection of Hepatocellular Carcinoma -- Chapter 32. Liver Transplantation for Hepatocellular Carcinoma -- Chapter 33. Medical Therapy of HCC -- Chapter 34. Targeted therapies for Hepatocellular Carcinoma -- Chapter 35. Radiation Therapy for Hepatocellular Carcinoma -- Chapter 36. Psychosocial Issues in Hepatocellular carcinoma -- Chapter 37. Bringing it all together.

Hepatocellular carcinoma (HCC) used to be regarded as a rare disease. However, the increasing numbers of chronic HCC carriers in the U.S. and subsequent increased incidences of HCC seen in most large medical centers means that it is no longer an uncommon disease for gastroenterologists or oncologists to encounter and its incidence and epidemiology are changing. During this exciting time in the field of HCC basic science and clinical management, many changes are simultaneously occurring at multiple levels of our understanding and management of the disease. Suddenly, there are several new choices of therapy to offer patients. Hepatocellular Carcinoma, 3rd edition addresses this fast-changing disease and gives the reader a clearer understanding of the many mechanisms involved in carcinogenesis of the liver. This comprehensive and detailed review of how to diagnose and treat hepatocellular carcinoma is written by international leaders in the field, covering both clinical treatment choices and the basic science underlying HCC development. Updated and enhanced from the last edition in 2009, Hepatocellular Carcinoma, 3rd edition features 12 new chapters including discussion of molecular markers, molecular hepatocarcinogenesis, microenvironment, heterogeneity, the new and exciting contributions of immunotherapy, and updates on the major effective hepatitis therapies that will transform HCC indidence and perhaps also the therapy. This cutting-edge text is a vital resource and must-have for today’s hepatologists and medical and surgical oncologists. "This is a well written text and should be a good reference book for those who see patients with HCC.." - Practical Gastroenterology "...a useful tool for both physicians and surgeons with a specific interest in the management of patients with HCC." - Digestive and Liver Disease.

ISBN: 9783319342146

Standard No.: 10.1007/978-3-319-34214-6doiSubjects--Topical Terms:

1253469
Oncology .

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Hepatocellular Carcinoma = Diagnosis and Treatment /
LDR:05933nam a22004095i 4500 001 973901
003 DE-He213
005 20200629150741.0
007 cr nn 008mamaa
008 201211s2016 gw | s |||| 0|eng d
020 $a 9783319342146 $9 978-3-319-34214-6
024 7 $a 10.1007/978-3-319-34214-6 $2 doi
035 $a 978-3-319-34214-6
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Hepatocellular Carcinoma $h [electronic resource] : $b Diagnosis and Treatment / $c edited by Brian I. Carr.
250 $a 3rd ed. 2016.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a XXI, 596 p. 129 illus., 80 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Current Clinical Oncology, $x 2364-1134
505 0 $a Part A. Causes, Biological and Molecular bases of HCC -- Chapter 1. Epidemiology of Hepatocellular Carcinoma -- Chapter 2. Environmental Carcinogens and Risk for Human Liver Cancer -- Chapter 3. Molecular Mechanisms of Hepatocellular Carcinoma -- Chapter 4. Chemically-Induced Hepatocarcinogenesis -- Chapter 5. Molecular Profiling of Human Hepatocellular Carcinoma -- Chapter 6. Genomic signatures of risk factors and molecular identification of HCC subtypes -- Chapter 7. MicroRNAs and hepatocellular carcinoma -- Chapter 8. Non-tumor prognostic factors in hepatocellular carcinoma -- Chapter 9. Gut microbiota and HCC -- Chapter 10. Hepatocellular Carcinoma as a Paradigm for a Systemic Evolutionary Approach to Cancer -- Chapter 11. HCC and its Microenvironment -- Chapter 12. Circulating tumor cells (Liquid Tumor Biopsy) in hepatocellular carcinoma: biology, methodologies, and clinical implications -- Chapter 13. Role of the immune system in hepatocellular carcinoma: Implications for existing and novel therapies -- Chapter 14. Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma -- Chapter 15. Systemic inflammation: a new prognostic domain and source of therapeutic targets in hepatocellular carcinoma -- Chapter 16. Hepatocellular Carcinoma Associated with Hepatitis B virus -- Chapter 17. Hepatitis C and Hepatocellular Carcinoma -- Chapter 18. Obesity, NASH and HCC -- Chapter 19. Metabolic Disease and Hepatocellular Carcinoma -- Part B. Diagnosis -- Chapter 20. Pathologic Aspects of Hepatocellular Tumors -- Chapter 21. Protein biomarkers in the management of hepatocellular carcinoma: Novel combinatory approaches -- Chapter 22. Surveillance for hepatocellular carcinoma -- Chapter 23. Use of Imaging Techniques to Screen for Hepatocellular Carcinoma -- Chapter 24. Ultrasound of Hepatocellular Carcinoma: The Important Contribution of Contrast Enhancement -- Chapter 25. MRI for Detection and Evaluation of Hepatocellular Carcinoma -- Chapter 26. Computed Tomography of HCC -- Chapter 27. Clinical features and clinician's diagnostic approach to hepatocellular carcinoma -- Chapter 28. Current HCC Staging systems: their uses and limitations -- Part C. Therapies -- Chapter 29. Percutaneous Ethanol Injection -- Chapter 30. Thermal Ablative Treatments For Hepatocellular Carcinoma -- Chapter 31. Resection of Hepatocellular Carcinoma -- Chapter 32. Liver Transplantation for Hepatocellular Carcinoma -- Chapter 33. Medical Therapy of HCC -- Chapter 34. Targeted therapies for Hepatocellular Carcinoma -- Chapter 35. Radiation Therapy for Hepatocellular Carcinoma -- Chapter 36. Psychosocial Issues in Hepatocellular carcinoma -- Chapter 37. Bringing it all together.
520 $a Hepatocellular carcinoma (HCC) used to be regarded as a rare disease. However, the increasing numbers of chronic HCC carriers in the U.S. and subsequent increased incidences of HCC seen in most large medical centers means that it is no longer an uncommon disease for gastroenterologists or oncologists to encounter and its incidence and epidemiology are changing. During this exciting time in the field of HCC basic science and clinical management, many changes are simultaneously occurring at multiple levels of our understanding and management of the disease. Suddenly, there are several new choices of therapy to offer patients. Hepatocellular Carcinoma, 3rd edition addresses this fast-changing disease and gives the reader a clearer understanding of the many mechanisms involved in carcinogenesis of the liver. This comprehensive and detailed review of how to diagnose and treat hepatocellular carcinoma is written by international leaders in the field, covering both clinical treatment choices and the basic science underlying HCC development. Updated and enhanced from the last edition in 2009, Hepatocellular Carcinoma, 3rd edition features 12 new chapters including discussion of molecular markers, molecular hepatocarcinogenesis, microenvironment, heterogeneity, the new and exciting contributions of immunotherapy, and updates on the major effective hepatitis therapies that will transform HCC indidence and perhaps also the therapy. This cutting-edge text is a vital resource and must-have for today’s hepatologists and medical and surgical oncologists. "This is a well written text and should be a good reference book for those who see patients with HCC.." - Practical Gastroenterology "...a useful tool for both physicians and surgeons with a specific interest in the management of patients with HCC." - Digestive and Liver Disease.
650 0 $a Oncology . $3 1253469
650 0 $a Hepatology. $3 673859
650 0 $a Surgical oncology. $3 1254222
650 0 $a Gastroenterology . $3 1254565
650 1 4 $a Oncology. $3 593951
650 2 4 $a Surgical Oncology. $3 673742
650 2 4 $a Gastroenterology. $3 673684
700 1 $a Carr, Brian I. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 676506
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319342122
776 0 8 $i Printed edition: $z 9783319342139
776 0 8 $i Printed edition: $z 9783319817057
830 0 $a Current Clinical Oncology, $x 2364-1134 $3 1268812
856 4 0 $u https://doi.org/10.1007/978-3-319-34214-6
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)